Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis

被引：60
|
作者：
Boissinot, Marjorie [1 ]
Lippert, Eric [1 ]
Girodon, Francois [1 ]
Dobo, Irene [1 ]
Fouassier, Marc [1 ]
Masliah, Claude [1 ]
Praloran, Vincent [1 ]
Hermouet, Sylvie [1 ]
机构：
[1] CHU Nantes, Lab Hematol, Inst Biol, F-44093 Nantes, France
来源：
BLOOD | 2006年 / 108卷 / 09期
关键词：
D O I：
10.1182/blood-2006-05-021527
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3223 / 3224
页数：2
相关论文
共 50 条
  • [31] Thrombosis in myeloproliferative neoplasia Influence of the mutation JAK2V617F
    Guy, Alexandre
    James, Chloe
    M S-MEDECINE SCIENCES, 2019, 35 (8-9): : 651 - 658
  • [32] The JAK2V617F tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis
    Goulding, C.
    Uttenthal, B.
    Foroni, L.
    Duke, V.
    Traore, A.
    Kottaridis, P.
    Hoffbrand, A. V.
    Patch, D.
    Mcnamara, C.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 (05) : 415 - 419
  • [33] JAK2-V617F Mutation and BCR-ABL Rearrangement in Chronic Myeloproliferative Neoplasms
    Zahra, M. K.
    El-Fadaly, N. H.
    Aboul-Enein, K. M.
    Elgamal, B. M.
    Abd El-Naby, Amira Y.
    Amer, Eman A.
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2012, 9 (02): : 403 - 414
  • [34] The JAK2 mutation V617F is specifically associated with idiopathic splanchnic vein thrombosis.
    Regina, Sandra
    Herault, Olivier
    D'alteroche, Louis
    Bacq, Yannick
    Domenenech, Jorge
    Binet, Christian
    Gruel, Yves
    BLOOD, 2006, 108 (11) : 117A - 117A
  • [35] JAK2V617F-Positive Latent Essential Thrombocythemia and Splanchnic Vein Thrombosis: The Role of Bone Marrow Biopsy for the Diagnosis of Myeloproliferative Disease
    Allegra, Alessandro
    Alonci, Andrea
    Penna, Giuseppa
    D'Angelo, Arianna
    Rizzotti, Patricia
    Granata, Angela
    Musolino, Caterina
    ACTA HAEMATOLOGICA, 2009, 121 (04) : 218 - 220
  • [36] Sagittal sinus thrombosis in jak-v617f mutation without overt myeloproliferative disorder
    Karde, Supriya
    Bhand, Prashant
    Ramesh, N.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S289 - S289
  • [37] Leukemic blasts in transfon-ned JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation
    Theocharides, Alexandre
    Boissinot, Marjorie
    Girodon, Francois
    Garand, Richard
    Teo, Soon-Siong
    Lippert, Eric
    Talmant, Pascaline
    Tichelli, Andre
    Hermouet, Sylvie
    Skoda, Radek C.
    BLOOD, 2007, 110 (01) : 375 - 379
  • [38] MASKED MYELOPROLIFERATIVE DISORDERS AND JAK2 (V617F) DETECTION IN SPLANCHNIC VEIN THROMBOSIS: A SINGLE CENTER EXPERIENCE
    Rago, A.
    Fama, A.
    Marzano, C.
    Mammi, C.
    Lagana, C.
    Bizzoni, L.
    D'Elia, G. M.
    Ribersani, M.
    Gioiosa, F.
    Natalino, F.
    Breccia, M.
    Carmosino, I
    Latagliata, R.
    Foa, R.
    Alimena, G.
    Riggio, O.
    Tafuri, A.
    HAEMATOLOGICA, 2008, 93 : S70 - S70
  • [39] Correlative study between the JAK2V617F mutation and thrombosis in patients with myeloproliferative neoplasm
    Li, Z. C.
    Fu, H. J.
    Wang, Z. M.
    Yang, S.
    Xu, H. Z.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (03):
  • [40] JAK2V617F mutation in patients with arterial thrombosis in the absence of overt myeloproliferative disease
    Dentali, F.
    Squizzato, A.
    Appio, L.
    Brivio, L.
    Ageno, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 740 - 740
12345